HealthDay - FRIDAY, Oct. 21 (HealthDay News) -- The breast cancer drug
letrozole, marketed as Femara, may be more effective than tamoxifen at
preventing the return of breast cancer and improving survival among older
women with hormone-sensitive breast cancers, a new study reports.
You are here:
Health 
Medications & Drugs Femara May Beat Tamoxifen at Preventing Breast Cancer's
Return
(HealthDay)
Medications & Drugs Femara May Beat Tamoxifen at Preventing Breast Cancer's
Return
(HealthDay)
